A Study of CDX-3379 and Cetuximab and in Patients With Advanced Head and Neck Squamous Cell Carcinoma

Condition:   Advanced Head and Neck Squamous Cell Carcinoma
Intervention:   Drug: CDX-3379 and cetuximab
Sponsor:   Celldex Therapeutics
Not yet recruiting - verified August 2017

http://ift.tt/2whgxaR